Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-60
SponsorMedipol University

About this trial

This study aims to compare the efficacy and safety of dapoxetine, Kegel exercises, acupuncture, and their placebo controls in the treatment of premature ejaculation (PE). PE is a common male sexual dysfunction characterized by ejaculation occurring within one minute of vaginal penetration, causing distress or interpersonal difficulties (Althof et al., 2014). A total of 250 male participants will be randomized into five groups (dapoxetine, placebo, Kegel exercises, acupuncture, sham acupuncture) for a 12-week treatment period followed by a 4-week follow-up. The primary outcome is the increase in intravaginal ejaculation latency time (IELT), with secondary outcomes including the Premature Ejaculation Diagnostic Tool (PEDT) score, Sexual Quality of Life-Male (SQoL-M) score, and adverse effects.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Male, aged 18-50 years. Diagnosed with lifelong or acquired PE per ISSM criteria (IELT < 2 minutes, lack of ejaculatory control, and associated distress or interpersonal difficulties).

Disqualifiers

Presence of erectile dysfunction (diagnosed via International Index of Erectile Function score < 21).

Trial design

Design model

Parallel

Treatments tested in this trial

  • serotonin reuptake inhibitor (SSRI)

    Drug

    Dapoxetine Group Dosage: 30 mg dapoxetine, taken orally 1-3 hours before anticipated sexual activity, with a maximum of 3 doses per week. Administration: Provided in blister packs to ensure compliance. Reference: McMahon et al., 2011.

  • Placebo

    Drug

    Dosage: Placebo tablets identical in appearance and taste to dapoxetine, administered on the same schedule (1-3 hours before sexual activity, maximum 3 doses per week). Administration: Provided in identical blister packs.

  • Acupuncture

    Other intervention

    Protocol: Two 30-minute acupuncture sessions per week, targeting standardized points (e.g., CV4, SP6, ST36) known to influence sexual function and autonomic nervous system regulation. Administration: Performed by licensed acupuncturists following a standardized protocol. Reference: Sunay et al., 2011.

  • Sham

    Other intervention

    Sham Acupuncture Group:Protocol: Two 30-minute sessions per week using superficial needle insertion at non-active points to minimize therapeutic effects while maintaining the placebo effect. Administration: Performed by licensed acupuncturists to ensure consistency with the active acupuncture group

  • Exercise

    Behavioral

    Kegel Exercises Group:Protocol: Participants will perform pelvic floor muscle exercises consisting of three sets of 10-15 contractions daily, each held for 5-10 seconds followed by relaxation. Training: Participants will receive initial training from a licensed physiotherapist, with weekly follow-up sessions to ensure proper technique and adherence. Reference: Pastore et al., 2014.

Treatment groups

250 Participants
are divided into 5 treatment groups
Group A: Dapoxetine Group:Experimental treatment 1 intervention
Group B: Placebo GroupPlacebo comparator 1 intervention
Group C: Kegel Exercises GroupExperimental treatment 1 intervention
Group D: Acupuncture GroupActive comparator 1 intervention
Group E: Sham Acupuncture GroupSham comparator 1 intervention

Trial outcomes

Primary outcomes

1

Intravaginal Ejaculation Latency Time (IELT):

Measured by stopwatch during sexual intercourse, reported as the weekly average. Participants will record IELT for each sexual encounter.

Time frame
Time points: Baseline, Week 4, Week 8, Week 12, and Follow-up (Week 16

Secondary outcomes

1

Premature Ejaculation Diagnostic Tool (PEDT):

A validated 5-item questionnaire assessing PE severity, including control, frequency, and distress (Symonds et al., 2007).

Time frame
Time points: Baseline, Week 4, Week 8, Week 12, and Follow-up (Week 16).

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: